Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Obalon Therapeutics Inc (OBLN)

Obalon Therapeutics Inc (OBLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,567
  • Shares Outstanding, K 10,022
  • Annual Sales, $ 1,590 K
  • Annual Income, $ -12,330 K
  • 60-Month Beta -1.23
  • Price/Sales 20.45
  • Price/Cash Flow N/A
  • Price/Book 3.24
Trade OBLN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.59
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/29/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.26 +34.96%
on 05/17/21
4.88 -37.50%
on 05/24/21
+0.66 (+27.62%)
since 05/14/21
3-Month
1.95 +56.41%
on 05/06/21
4.88 -37.50%
on 05/24/21
-0.61 (-16.67%)
since 03/15/21
52-Week
0.66 +362.12%
on 08/03/20
10.77 -71.68%
on 01/20/21
+2.07 (+211.86%)
since 06/15/20

Most Recent Stories

More News
ReShape Lifesciences Completes Merger with Obalon Therapeutics

Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS"

OBLN : 3.05 (-5.86%)
RSLS : 6.30 (-31.15%)
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger

SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the anticipated closing of their previously...

RSLS : 6.30 (-31.15%)
OBLN : 3.05 (-5.86%)
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger

SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today that the parties anticipate the closing...

RSLS : 6.30 (-31.15%)
OBLN : 3.05 (-5.86%)
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric...

RSLS : 6.30 (-31.15%)
OBLN : 3.05 (-5.86%)
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric...

RSLS : 6.30 (-31.15%)
OBLN : 3.05 (-5.86%)
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021

Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc.

RSLS : 6.30 (-31.15%)
OBLN : 3.05 (-5.86%)
Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc

SAN DIEGO, CA / ACCESSWIRE / May 12, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN) is urging its stockholders to IMMEDIATELY vote FOR the proposals put forth in its proxy statement to be voted on at the...

OBLN : 3.05 (-5.86%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, OBLN, FI, and BMTC Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

NTWN : 9.2000 (-2.54%)
OBLN : 3.05 (-5.86%)
FI : 3.52 (+2.33%)
BMTC : 46.89 (+0.34%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds FLIR, NTWN, OBLN, and GLUU Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

FLIR : 57.34 (-0.31%)
NTWN : 9.2000 (-2.54%)
OBLN : 3.05 (-5.86%)
GLUU : 12.50 (+0.08%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds TLRY, CBLI, AKER and OBLN Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

TLRY : 18.13 (+0.83%)
CBLI : 5.03 (-3.27%)
AKER : 2.47 (-9.52%)
OBLN : 3.05 (-5.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company's product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained...

See More

Key Turning Points

3rd Resistance Point 6.10
2nd Resistance Point 5.45
1st Resistance Point 4.25
Last Price 3.05
1st Support Level 2.40
2nd Support Level 1.75
3rd Support Level 0.55

See More

52-Week High 10.77
Fibonacci 61.8% 6.91
Fibonacci 50% 5.72
Fibonacci 38.2% 4.52
Last Price 3.05
52-Week Low 0.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar